Supplements9 min read
Peppermint oil for IBS: why enteric coating matters
Enteric coating changes peppermint oil delivery, but the IBS evidence still depends on the preparation, symptom outcome and tolerability.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Explore the articles
Find a topic you’re curious about and take a closer look.
Peptides9 min read
What a MOTS-c blood test can and cannot tell you
MOTS-c blood measurements are scientifically interesting, but assay differences and missing clinical thresholds limit what an individual result can tell you.
Read article
Peptides9 min read
GHK-Cu for skin: what the small human studies actually measured
What small GHK-Cu trials measured in wrinkles, laser recovery, ulcers, and eyebrows—and where cosmetic claims exceed those findings.
Read article
Peptides9 min read
CJC-1295 with DAC or no DAC: why the name changes the evidence
DAC changes the molecule and its exposure. Learn which CJC-1295 form was studied and why no-DAC labels cannot inherit its clinical results.
Read article
Peptides9 min read
Semax and ADHD: a plausible mechanism is not a tested treatment
ADHD claims need studies of the diagnosis and its daily effects. Semax mechanisms, small healthy-volunteer experiments and older report citations do not settle that question.
Read article
Peptides9 min read
Thymosin alpha-1 and long COVID: what the studies actually tested
Hospital trials and diluted blood-sample experiments ask different questions. Here is what thymosin alpha-1 research can tell people living with long COVID.
Read article
Supplements9 min read
Saffron for mood: encouraging research is not the same as interchangeable treatment
Saffron trials show mood benefits in selected groups, but treatment equivalence, extract differences and mixed self-ratings need careful explanation.
Read article
Peptides9 min read
BPC-157 and gut healing: start with the diagnosis
Gut healing is not a diagnosis. BPC-157's limited human ulcerative-colitis evidence cannot establish a treatment for IBS, celiac disease or every digestive symptom.
Read article
Peptides9 min read
MOTS-c rises with exercise: why that does not prove injections mimic exercise
Human exercise studies measured the body's own MOTS-c. Mouse treatment experiments and a newer trial registration cannot yet show that injections reproduce exercise.
Read article
Peptides9 min read
KPV and gut health: what counts as human evidence, and what does not?
Learn which KPV studies used cells or tissue, why K(D)PT is a different peptide, and what human gut-treatment evidence is still missing.
Read article
Peptides9 min read
Amycretin became zenagamtide: why the name matters
The molecule did not change when the name changed. Following its evidence means connecting aliases while keeping oral, injected and diabetes studies distinct.
Read article
Peptides9 min read
Does a BPC-157 and TB-500 stack have combination evidence?
A 2026 rat study directly tested the combination, but found no added benefit. A small human report also cannot establish that the stack improves recovery.
Read article254–265 of 600 articles